Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

Pfizer and Mylan Partner to Develop Generic Drugs in Japan

August 27, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Pfizer and Mylan have agreed to establish an exclusive long-term collaboration to develop, manufacture, distribute, and market generic drugs in Japan. The products included in the collaboration are expected to be sold under the Pfizer brand with joint labeling.

Myriad Genetics Receives Favorable Ruling on Gene Patentability

August 22, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Myriad Genetics reported that a US federal appeals court has ruled that the company's composition of matter claims covering isolated DNA of the BRCA 1 and BRCA 2 genes are patent-eligible material under federal patent law. The court, however, denied the company's effort to patent methods of "comparing" or "analyzing" DNA sequences.

Eli Lilly Receives $1.3 Billion Following Bristol-Myers Squibb's Acquisition of Amylin Pharmaceuticals

August 22, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Eli Lilly has received $1.3 billion for payment of financial obligations from Amylin Pharmaceuticals following Bristol-Myers Squibb's acquisition of Amylin Pharmaceuticals earlier this month.

Grey-Market Distributor Convicted of Defrauding FDA

August 20, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

South Carolina-based Altec Medical pleaded guilty to one count of conspiring to defraud FDA and to commit federal offenses in connection with a drug-diversion scheme that lasted from 2007 to 2009.

AstraZeneca and Bristol-Myers Squibb Extend Diabetes Alliance

August 13, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

AstraZeneca has paid approximately $3.2 billion to extend its diabetes alliance with Bristol-Myers Squibb (BMS), following BMS's recently completed acquisition of Amylin Pharmaceuticals.

Elan to Spin Off Discovery Sciences

August 13, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Elan Corporation announced plans to spin off its discovery unit and Neotope Biosciences division to create an independent entity focused on R&D.

Pfizer Settles with DOJ and SEC on Improper Conduct in Select Emerging Markets

August 7, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

An internal investigation and voluntary disclosure by Pfizer led to a settlement with the US Department of Justice and Securities and Exchange Commission.

Carbon Measurement Methods for Cleaning Validation (Peer Reviewed)

August 2, 2012

Pharmaceutical Technology

The authors compare direct combustion with rinse and swab sampling methods.

Measuring Growth in Big Pharma's Manufacturing Investment

August 2, 2012

Pharmaceutical Technology

Pharmaceutical Technology's annual manufacturing investment update shows slight gains in biopharmaceutical manufacturing and emerging markets and continued restructuring of supply networks.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here